CBFb-SMMHC Affects Genome-wide Polycomb Repressive Complex 1 Activity in Acute Myeloid Leukemia

[1]  L. Morey,et al.  Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer. , 2019, Trends in biochemical sciences.

[2]  L. Di Croce,et al.  Polycomb complexes in normal and malignant hematopoiesis , 2018, The Journal of cell biology.

[3]  Ho Lam Chan,et al.  Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanisms , 2018, Nature Communications.

[4]  Li Ding,et al.  Driver Fusions and Their Implications in the Development and Treatment of Human Cancers , 2018, Cell reports.

[5]  A. Iwama.  Polycomb repressive complexes in hematological malignancies. , 2017, Blood.

[6]  R. Sood,et al.  Role of RUNX1 in hematological malignancies. , 2017, Blood.

[7]  M. Vidal,et al.  Polycomb complexes PRC1 and their function in hematopoiesis. , 2017, Experimental hematology.

[8]  J. Martens,et al.  CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesis , 2017, Leukemia.

[9]  Emily C. Dykhuizen,et al.  Compositional and functional diversity of canonical PRC1 complexes in mammals. , 2017, Biochimica et biophysica acta. Gene regulatory mechanisms.

[10]  K. Helin,et al.  Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer. , 2016, Cold Spring Harbor perspectives in medicine.

[11]  H. Stunnenberg,et al.  Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis. , 2016, Cell reports.

[12]  B. Johansson,et al.  The emerging complexity of gene fusions in cancer , 2015, Nature Reviews Cancer.

[13]  G. Duester,et al.  Retinoic acid controls body axis extension by directly repressing Fgf8 transcription , 2014, Development.

[14]  Ya-jun Guo,et al.  Ezh2 Regulates Transcriptional and Posttranslational Expression of T-bet and Promotes Th1 Cell Responses Mediating Aplastic Anemia in Mice , 2014, The Journal of Immunology.

[15]  Tim J. Wigle,et al.  Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma , 2014, Molecular Cancer Therapeutics.

[16]  H. Aburatani,et al.  Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations. , 2013, The Journal of clinical investigation.

[17]  K. Helin,et al.  Transcriptional regulation by Polycomb group proteins , 2013, Nature Structural &Molecular Biology.

[18]  K. Helin,et al.  Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation. , 2013, Molecular cell.

[19]  Peter W. Laird,et al.  Interplay between the Cancer Genome and Epigenome , 2013, Cell.

[20]  G. Haan,et al.  Polycomb-group proteins in hematopoietic stem cell regulation and hematopoietic neoplasms , 2013, Leukemia.

[21]  H. Stunnenberg,et al.  ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia. , 2012, Blood.

[22]  Peter A. Jones,et al.  Cancer genetics and epigenetics: two sides of the same coin? , 2012, Cancer cell.

[23]  Edwin Cheung,et al.  A transcriptional repressor co‐regulatory network governing androgen response in prostate cancers , 2012, The EMBO journal.

[24]  N. Tommerup,et al.  REST–Mediated Recruitment of Polycomb Repressor Complexes in Mammalian Cells , 2012, PLoS genetics.

[25]  Candace R. Chouinard,et al.  Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. , 2012, Molecular cell.

[26]  W. Ouwehand,et al.  Genome-wide Analysis of Simultaneous GATA1/2, RUNX1, FLI1, and SCL Binding in Megakaryocytes Identifies Hematopoietic Regulators , 2011, Developmental cell.

[27]  A. Iwama,et al.  Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells , 2011, Leukemia.

[28]  D. Reinberg,et al.  The Polycomb complex PRC2 and its mark in life , 2011, Nature.

[29]  Bradley E. Bernstein,et al.  GC-Rich Sequence Elements Recruit PRC2 in Mammalian ES Cells , 2010, PLoS genetics.

[30]  E. Vellenga,et al.  BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. , 2010, Blood.

[31]  R. Copeland,et al.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas , 2010, Proceedings of the National Academy of Sciences.

[32]  A. Friedman,et al.  Phosphorylation of RUNX1 by Cyclin-dependent Kinase Reduces Direct Interaction with HDAC1 and HDAC3* , 2010, The Journal of Biological Chemistry.

[33]  W. Ouwehand,et al.  Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. , 2010, Cell stem cell.

[34]  M. Carroll,et al.  AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3 , 2010, Leukemia.

[35]  H. Drexler,et al.  Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders , 2010, Nature Genetics.

[36]  Luca Mazzarella,et al.  Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators , 2010, Nature Cell Biology.

[37]  Cory Y. McLean,et al.  GREAT improves functional interpretation of cis-regulatory regions , 2010, Nature Biotechnology.

[38]  K. Link,et al.  Core binding factor at the crossroads: Determining the fate of the HSC , 2010, Journal of cellular physiology.

[39]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[40]  D. Voon,et al.  PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis. , 2008, Blood.

[41]  W. Alkema,et al.  BioVenn – a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams , 2008, BMC Genomics.

[42]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[43]  B. Johansson,et al.  The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.

[44]  J. Zeitlinger,et al.  Polycomb complexes repress developmental regulators in murine embryonic stem cells , 2006, Nature.

[45]  Kristian Helin,et al.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. , 2006, Genes & development.

[46]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[47]  M. Kundu,et al.  Cbf beta is involved in maturation of all lineages of hematopoietic cells during embryogenesis except erythroid. , 2003, Blood cells, molecules & diseases.

[48]  D. Gilliland,et al.  Core-binding factors in haematopoiesis and leukaemia , 2002, Nature Reviews Cancer.

[49]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[50]  Jerónimo Bravo,et al.  The leukemia-associated AML1 (Runx1)–CBFβ complex functions as a DNA-induced molecular clamp , 2001, Nature Structural Biology.

[51]  S. Hiebert,et al.  The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.

[53]  A. Berns,et al.  Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. , 1999, Genes & development.

[54]  M. Ohki,et al.  Interaction and functional cooperation of the leukemia‐associated factors AML1 and p300 in myeloid cell differentiation , 1998, The EMBO journal.

[55]  Y. Kanno,et al.  Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation. , 1998, Molecular and cellular biology.

[56]  N. Speck,et al.  The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. , 1998, Molecular and cellular biology.

[57]  F. Collins,et al.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.